股本结构
单位：万股
| 公告日期 | 2026-09-10 | 2026-09-10 | 2026-08-10 | 2026-08-10 | 2026-06-23 | 2026-06-15 |
|---|---|---|---|---|---|---|
| 证券总股本 | 2880.54 | 2619.47 | 2593.64 | 2593.34 | 2593.19 | 2593.34 |
| 普通股本 | 2880.54 | 2619.47 | 2593.64 | 2593.34 | 2593.19 | 2593.34 |
| 优先股 | 未披露 | 未披露 | 未披露 | 0.60 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-09-10 | 2026-09-08 | 2026-08-10 | 2026-06-30 | 2026-06-15 | 2026-06-12 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-09-10 | 2880.54 | 未披露 |
更多>>
Common stock offered 2,610,715 shares by the company
|
2026-09-10 |
| 2026-09-10 | 2619.47 | 未披露 | 定期报告 | 2026-09-08 |
| 2026-08-10 | 2593.64 | 未披露 | 定期报告 | 2026-08-10 |
| 2026-08-10 | 2593.34 | 0.60 |
更多>>
From March 31,2026 to June 30,2026
Series A preferred shares issued, net of derivative allocation and issuance costs
Restricted share grants released from restriction
Common stock issued for private placement
Tax effect related to net share settlement of equity awards
|
2026-06-30 |
| 2026-06-23 | 2593.19 | 未披露 | 定期报告 | 2026-06-15 |
| 2026-06-15 | 2593.34 | 未披露 | 定期报告 | 2026-06-12 |
| 2026-05-15 | 2601.31 | 未披露 | 定期报告 | 2026-05-15 |
| 2026-05-05 | 2528.55 | 未披露 | 定期报告 | 2026-05-04 |
| 2026-06-15 | 2519.43 | 未披露 | 定期报告 | 2026-04-30 |
| 2026-04-24 | 2518.93 | 未披露 |
更多>>
Common Stock offered 277,777 shares by the company
|
2026-04-20 |
| 2026-04-10 | 2491.15 | 未披露 | 定期报告 | 2026-04-08 |
| 2026-05-15 | 2482.52 | 未披露 |
更多>>
From December 31,2025 to March 31,2026
Tax effect related to net share settlement of equity awards
Restricted share grants released from restrictions
Common stock issued for equity line of credit
Common stock issued for advisory services
Common stock issued for private placement
|
2026-03-31 |
| 2026-03-31 | 2380.62 | 未披露 | 定期报告 | 2026-03-30 |
| 2026-02-06 | 2269.22 | 未披露 | 定期报告 | 2026-01-29 |
| 2026-03-31 | 2199.07 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Common stock issued for $16/share net of listing costs
Common stock issued for advisory services
Cashless exercise of warrants
Restricted share grants released from restrictions
Common stock issued for equity line of credit
Common stock issued for private placement
Tax effect related to net share settlement of equity awards
|
2025-12-31 |
| 2025-12-15 | 2397.08 | 未披露 | 定期报告 | 2025-12-10 |
| 2025-12-15 | 2397.08 | 未披露 | 定期报告 | 2025-12-09 |
| 2025-11-14 | 1947.43 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Proceeds from sale of common stock pursuant to equity line of credit
|
2025-09-30 |
| 2025-08-18 | 1915.91 | 未披露 | 定期报告 | 2025-08-18 |
| 2025-06-16 | 1902.68 | 未披露 | 定期报告 | 2025-05-27 |
| 2025-05-09 | 1902.68 | 未披露 | 定期报告 | 2025-05-09 |
| 2025-04-29 | 1901.08 | 未披露 | 定期报告 | 2025-04-28 |
| 2025-05-09 | 1902.68 | 未披露 |
更多>>
From January 1, 2025 to March 31, 2025
Sale of common stock, net of offering costs
Common stock issued for advisory services
Cashless exercise of warrants
|
2025-03-31 |
| 2025-03-25 | 1874.59 | 未披露 | 定期报告 | 2025-03-26 |
Common stock offered 2,610,715 shares by the company
From March 31,2026 to June 30,2026
Series A preferred shares issued, net of derivative allocation and issuance costs
Restricted share grants released from restriction
Common stock issued for private placement
Tax effect related to net share settlement of equity awards
Common Stock offered 277,777 shares by the company
From December 31,2025 to March 31,2026
Tax effect related to net share settlement of equity awards
Restricted share grants released from restrictions
Common stock issued for equity line of credit
Common stock issued for advisory services
Common stock issued for private placement
From December 31, 2024 to December 31, 2025
Common stock issued for $16/share net of listing costs
Common stock issued for advisory services
Cashless exercise of warrants
Restricted share grants released from restrictions
Common stock issued for equity line of credit
Common stock issued for private placement
Tax effect related to net share settlement of equity awards
From June 30, 2025 to September 30, 2025
Proceeds from sale of common stock pursuant to equity line of credit
From January 1, 2025 to March 31, 2025
Sale of common stock, net of offering costs
Common stock issued for advisory services
Cashless exercise of warrants